These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure. Lamblin N; Mouquet F; Hennache B; Dagorn J; Susen S; Bauters C; de Groote P Eur Heart J; 2005 Nov; 26(21):2245-50. PubMed ID: 16183690 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. van der Meer P; Voors AA; Lipsic E; Smilde TD; van Gilst WH; van Veldhuisen DJ J Am Coll Cardiol; 2004 Jul; 44(1):63-7. PubMed ID: 15234408 [TBL] [Abstract][Full Text] [Related]
11. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes. Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435 [TBL] [Abstract][Full Text] [Related]
12. Serum hepatocyte growth factor levels are increased in patients with congestive heart failure. Ueno S; Ikeda U; Hojo Y; Arakawa H; Nonaka M; Yamamoto K; Shimada K J Card Fail; 2001 Dec; 7(4):329-34. PubMed ID: 11782856 [TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor and vascular endothelial growth factor in ischaemic heart disease. Suzuki H; Murakami M; Shoji M; Iso Y; Kondo T; Shibata M; Ezumi H; Hamazaki Y; Koba S; Katagiri T Coron Artery Dis; 2003 Jun; 14(4):301-7. PubMed ID: 12826929 [TBL] [Abstract][Full Text] [Related]
14. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772 [TBL] [Abstract][Full Text] [Related]
15. Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma. Alexandrakis MG; Sfiridaki A; Miyakis S; Pappa C; Kandidaki E; Alegakis A; Margioris AN Clin Chim Acta; 2007 Apr; 379(1-2):31-5. PubMed ID: 17234170 [TBL] [Abstract][Full Text] [Related]
16. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment]. Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626 [TBL] [Abstract][Full Text] [Related]